Understand the source comparison
Best Peptides for High Cholesterol: Research-Grade Comparison
Thymalin Immune modulation via thymic peptide bioregulation Reduces hepatic inflammation that drives cholesterol synthesis 5–10mg subcutaneous 2–3x/week for 8–12 weeks 6–10 weeks for lipid panel changes Best for individuals with chronic inflammation or immune
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Thymalin
- Immune modulation via thymic peptide bioregulation
- Reduces hepatic inflammation that drives cholesterol synthesis
- 5–10mg subcutaneous 2–3x/week for 8–12 weeks
- 6–10 weeks for lipid panel changes
- Best for individuals with chronic inflammation or immune dysregulation driving metabolic dysfunction
- MK-677 (Ibutamoren)
- Ghrelin receptor agonist. Stimulates endogenous GH/IGF-1
- Increases lipolysis, reduces visceral fat, improves insulin sensitivity
- 12.5–25mg oral daily, preferably before bed
- 8–16 weeks for body composition and lipid changes
- Strong evidence for visceral fat reduction; neutral to slightly negative direct LDL effect in some individuals
- CJC-1295/Ipamorelin
- Dual GH secretagogue. GHRH analog + GHRP
- Pulsatile GH elevation improves fat oxidation and metabolic efficiency
- 100–200mcg each peptide subcutaneous before bed, 5 days/week
- 10–14 weeks for measurable lipid and body comp changes
- Preferred for physiologic GH pulsatility; lower insulin resistance risk than continuous elevation
- Cartalax
- Bioregulatory peptide targeting cellular aging pathways
- Improves mitochondrial function, shifts energy metabolism from storage to oxidation
- 10–20mg subcutaneous 2–3x/week for 4–8 weeks
- 8–12 weeks for metabolic adaptation
- Emerging evidence; mechanism less understood than GH or immune pathways
- This table distills mechanism, application context, and realistic timelines. No peptide listed here operates as a statin replacement. They are adjunctive tools for metabolic optimization, not acute lipid-lowering agents.